RhumbLine Advisers’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $134K | Sell |
|
|||||
|
2025
Q2 | $137K | Buy |
|
|||||
|
2025
Q1 | $171K | Buy |
|
|||||
|
2024
Q4 | $183K | Buy |
|
|||||
|
2024
Q3 | $149K | Buy |
|
|||||
|
2024
Q2 | $229K | Buy |
|
|||||
|
2024
Q1 | $84.4K | Buy |
|
|||||
|
2023
Q4 | $87.9K | Buy |
|
|||||
|
2023
Q3 | $134K | Buy |
|
|||||
|
2023
Q2 | $134K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $134K | Buy |
|
|||||
|
2021
Q4 | $354K | Buy |
|
|||||
|
2021
Q3 | $450K | Buy |
|
|||||
|
2021
Q2 | $440K | Buy |
|
|||||
|
2021
Q1 | $314K | Sell |
|
|||||
|
2020
Q4 | $215K | Buy |
|
|||||
|
2020
Q3 | $152K | Sell |
|
|||||
|
2020
Q2 | $211K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $81K | Buy |
|
|||||
|
2018
Q4 | $63K | Buy |
|
|||||
|
2018
Q3 | $246K | Sell |
|
|||||
|
2018
Q2 | $222K | Buy |
|
|||||
|
2018
Q1 | $119K | Buy |
|
|||||
|
2017
Q4 | $105K | Sell |
|
|||||
|
2017
Q3 | $227K | Buy |
|
|||||
|
2017
Q2 | $239K | Buy |
|